Medclair AB (NGM:MCLR)
Sweden · Delayed Price · Currency is SEK 2.960
-0.100 (-3.27%)
At close: Sep 3, 2026
Medclair AB Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 271 | 246 | 114 | 138 | 103 | 222 | |
Market Cap Growth | 6.08% | 115.94% | -17.76% | 34.89% | -53.75% | 246.07% |
Enterprise Value | 252 | 244 | 112 | 138 | 97 | 213 |
Last Close Price | 2.96 | 2.98 | 1.38 | 1.68 | 1.24 | 2.69 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 183.42 | 52.83 | - | - | - | - |
Forward PE | - | 5.51 | 5.51 | 5.51 | 6.46 | - |
PS Ratio | 5.01 | 4.39 | 3.17 | 3.26 | 3.64 | 16.66 |
PB Ratio | 3.45 | 4.58 | 2.32 | 2.77 | 1.95 | 3.84 |
P/TBV Ratio | 6.16 | 7.29 | 4.36 | 5.88 | 4.49 | 9.01 |
P/FCF Ratio | 201.69 | 35.59 | 95.58 | 32.73 | - | - |
P/OCF Ratio | 189.04 | 35.13 | 35.27 | 26.31 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.66 | 4.35 | 3.11 | 3.24 | 3.46 | 15.96 |
EV/EBITDA Ratio | 36.37 | 23.44 | - | 73.04 | 839.62 | - |
EV/EBIT Ratio | 117.84 | 42.82 | - | - | - | - |
EV/FCF Ratio | 187.66 | 35.33 | 93.98 | 32.54 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | - | - | - | 0.01 | 0.02 | 0.02 |
Debt / EBITDA Ratio | - | - | - | 0.21 | 7.61 | - |
Debt / FCF Ratio | - | - | - | 0.09 | - | - |
Net Debt / Equity Ratio | -0.24 | -0.11 | -0.05 | -0.06 | -0.06 | -0.33 |
Net Debt / EBITDA Ratio | -2.72 | -0.55 | 1.73 | -1.49 | -25.90 | 2.13 |
Net Debt / FCF Ratio | -14.03 | -0.83 | -2.17 | -0.66 | 0.26 | 2.17 |
Asset Turnover | - | 0.93 | 0.61 | 0.69 | 0.44 | 0.24 |
Inventory Turnover | - | 2.65 | 1.54 | 1.59 | 0.84 | 1.58 |
Quick Ratio | 2.38 | 1.64 | 0.90 | 1.03 | 0.77 | 3.73 |
Current Ratio | 3.84 | 3.06 | 1.79 | 2.08 | 2.16 | 4.60 |
Return on Equity (ROE) | - | 9.06% | -1.34% | -5.42% | -9.05% | -26.80% |
Return on Assets (ROA) | - | 5.91% | -6.50% | -2.68% | -3.86% | -14.50% |
Return on Capital Employed (ROCE) | 2.70% | 10.60% | -12.60% | -5.30% | -7.50% | -21.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.55% | 1.89% | -0.58% | -2.01% | -4.87% | -5.87% |
FCF Yield | 0.50% | 2.81% | 1.05% | 3.06% | -11.47% | -3.91% |
Buyback Yield / Dilution | - | -16.79% | 28.47% | -11.40% | -2.41% | - |